Market Research Future published a research report on Global Diabetic Nephropathy Market and predicts that Global Diabetic Nephropathy Market is expected to grow at a healthy CAGR of 5.2% during the forecasted period and report include market Analysis, Scope, Stake, Progress, Trends and forecast till 2023.
Diabetic nephropathy, also known as diabetic kidney disease, is a kidney-related disease to type 1 and type 2 diabetes. This condition affects the normal functioning of the kidney and disturbs its ability to remove waste products and extra fluid from the body. Diabetes and high blood pressure are the major risk factors for diabetic nephropathy. Preventive care includes following a healthy lifestyle and proper monitoring and treatment of high blood pressure and diabetes. Early diagnosis and treatment help to reduce further damage to the kidney, thereby helping in disease management. If left untreated, it may lead to kidney failure, a severe and life-threatening condition.
Factors driving the growth of the market are rising prevalence of chronic diseases diabetes, obesity and increasing demand for diagnostic tests such as urine test, blood test, kidney biopsy, and imaging tests such as MRI and CT scan. As per the data by World Health Organization (WHO), chronic diseases account for nearly 59% of the mortality and death toll due to chronic disease is as high as 35 million across the globe. Furthermore, technological advancements in diagnostic imaging and increasing focus on early diagnosis of diseases also influence the market growth. The accuracy of a diagnostic test for the diagnosis of diabetic nephropathy and the high cost of imaging devices restrain the market growth. Significant growth of medical device industry and availability of cutting-edge technologies for diagnosis further stimulates the market growth.
Global Diabetic Nephropathy Market is expected to grow at a CAGR of 5.2% during the forecast period.
To Explore More, Get PDF Sample Copy @ https://www.marketresearchfuture.com/sample_request/5664 .
Key Players for Global Diabetic Nephropathy Market
Some of the key players in this market are Merck & Co., Inc. (U.S.), Bayer AG (Germany), Abbott (U.S.), Sanofi (France), Novartis AG (Switzerland), Reata Pharmaceuticals, Inc. (U.S.), Pfizer Inc. (U.S.), AbbVie Inc. (U.S.), Eli Lilly and Company (U.S.), General Electric Company (U.S.), Siemens AG (Germany), Mitsubishi Tanabe Pharma Corporation (Japan) and others.
Research Methodology for Global Diabetic Nephropathy Market
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Segments for Global Diabetic Nephropathy Market
The Global Diabetic Nephropathy Market is segmented on the basis of diagnosis, treatment, indication, and end user.
On the basis of diagnosis, the market is segmented into blood test, urine tests, imaging tests, renal function testing and kidney biopsy.
On the basis of treatment, the market is segmented into medications, kidney dialysis, and transplant. On the basis of indication, the market is segmented into Diabetes 1 and Diabetes 2.
On the basis of the end user, the market is segmented into hospital & clinics, diagnostic center, research institutes, and others.
Regional Analysis for Global Diabetic Nephropathy Market
America diabetic nephropathy is the largest across the globe and is driven by the extensive use of diagnostic tests, rising emphasis on diagnosis and continuous monitoring of diabetes and high blood pressure.
Europe Diabetic Nephropathy Market is driven by increasing demand for diagnostics services and growing emphasis on home diagnosis, especially for the geriatric population, with Germany being the largest market.
In Asia Pacific, an alarming increase in the prevalence of chronic disease such as cardiovascular diseases, kidney disease, obesity, diabetes, especially among the geriatric population is a major factor driving the market growth. China and India have the largest diabetic population which is expected to increase drastically in the near future, thereby accelerating the market growth.
The market in Middle East & Africa demonstrates steady progress with rising number of diagnostic services, and growing emphasis on diagnosis and treatment of kidney disease. Major economies contributing to the market growth are Saudi Arabia and Unites Arab Emirates (UAE), due to the availability of specialty healthcare services and rising usage of diagnostic devices.
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/5664 .
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/5664 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312